Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%

← Back to our analysis

Original News Release Routine +

Market One: Rise Nano Optics Secures First U.S. Lab Partnership as SPECTRAGUARD(TM) Commercialization Advances

Rise Nano Optics Ltd. Apr 23, 2026 · 12:45 EYE As distributed — unedited
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors. Market One delivers content creation and distribution through a suite of products across video, editorial, and social media. Rise Nano Optics Ltd.: Commercializing Its Patented SPECTRAGUARD™ Nanotechnology Lens Treatment Rise Nano Optics Ltd. (CSE: EYE) (the "Company" or "Rise") reviewed its commercialization progress for its patented SPECTRAGUARD™ nanotechnology lens treatment, including its registration as an FDA-registered Class I device, and the signing of its first U.S. lab partnership with Sierra Optical Lab, a VSP®-authorized facility in Reno, Nevada. The article examines Rise Nano Optics' partnership-driven commercialization strategy for its advanced protective lens coating, against the backdrop of growing demand for functional premium eyewear within the USD$160 billion global eyewear market. The Company is targeting distribution across North America through clinical channel partnerships and direct-to-consumer platforms. To read the full article, please visit BNN Bloomberg at: https://www.bnnbloomberg.ca/investment-trends/2026/04/21/rise-nano-optics-secures-first-us-lab-partnership-as-spectraguard-commercialization-advances/ About Rise Nano Optics Ltd.: Rise Nano Optics Ltd. is a health technology company specializing in advanced nanotechnology lens solutions designed to filter high-energy visible light and UV wavelengths without compromising visual clarity or colour perception. Its patented SPECTRAGUARD™ technology is commercialized through a capital-efficient lab partnership model, serving eye care professionals and direct-to-consumer eyewear platforms globally. To learn more about Rise, visit their website. For the latest updates, follow Rise on social media: LinkedIn, X, and Instagram. Investor Contacts: Inas Said Chief Executive Officer Rise Nano Optics Ltd. Email: [email protected] Danielle Shortall Corporate Communications Email: [email protected] Tel: +1 (437) 226 0612 About Market One Market One is a Canadian marketing agency for public companies, delivering best-in-class content creation and distribution. The firm helps position companies for meaningful engagement through a suite of products across video, editorial, and social media. Clients benefit from increased visibility and strengthened awareness through Market One's content and relationships with industry-leading media outlets. To learn more about Market One, visit its website. Contact: Brett Yelland [email protected] or +1 (604)-250-4082 To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294003
View at source ↗